Searched for
ANTIBIOTIC INNOVATION
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
- Metals rally largely priced in, limited upside seen after strong cyclical run: Sandip SabharwalMarket expert Sandip Sabharwal advises caution, seeing stock-specific chances but limited broad market conviction. He notes Wockhardt's app...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- Trump-Xi meeting crucial for global economic stability: Shaun ReinA high-stakes meeting between US President Trump and Chinese President Xi Jinping is closely watched for signs of stability amid escalating...
- Elmed Life Sciences raises $2.7 million from Nabard-backed Agrisure FundElmed Life Sciences has raised $2.7 million from Agrisure Fund, which is managed by Nabard-backed Nabventures. The company develops and man...
- Kathua to become India’s antibiotic powerhouse with Rs 600 crore pharma facilityA groundbreaking ceremony led by Union Minister Jitendra Singh has marked the start of a new Rs 600 crore pharmaceutical manufacturing plan...
- Decoding the antibiotic resistance crisis: How everyday habits can save our strongest medicinesAntibiotics are losing their power as germs grow stronger, a crisis fueled by everyday misuse. Experts urge parents to rethink treating min...
- Artificial Intelligence designs two potential antibiotics to combat drug-Resistant Gonorrhoea and MRSAResearchers have used AI to design two promising antibiotics that are helpful in combating drug-resistant bacteria, including gonorrhoea an...
- Superbug-related death spurs drug regulator warningThe Centre has also asked state drug regulators to take "strong policy measures including stringent regulatory action on the over-the-count...
- Buy Dishman Carbogen Amcis, target Rs 355: HDFC SecuritiesBuy Dishman Carbogen Amcis Ltd. at a price target of Rs 355.
- Bugworks Research wins Top Innovator at ET Startup Awards 2017"At a time where the business narrative is predominantly dominated by tech, it is so heartening to see the Economics Times giving a platfor...
- ET Startup Awards 2017: Both Bugworks Research & Pandorum Technologies grab 'Top Innovator' awardDespite the complexities, long durations and dearth of money required for such research, several young companies are making a global impact...
- Do you pop pills without consulting a doctor? Inappropriate intake of antibiotics can destroy ‘good bacteria'Cautious use includes taking antibiotics only for diagnosed bacterial infections.
- Scientists create new antibiotic Teixobactin in 30 yearsTeixobactin can treat many common bacterial infections such as tuberculosis, septicemia and C Diff or clostridium difficile colitis.
- Cadila Pharma, Helperby sign licensing deal on antibiotic drug resistanceDescribed as the most important innovation in the discovery of antibiotics since Alexander Fleming's original breakthrough more than 80 yea...
- Cadila Pharmaceuticals Ltd & Helperby sign licensing deal on antibiotic drug resistanceHelperby will supply Cadila Pharma with Antibiotic Resistance Breakers whilst Cadila will develop the combinations with old antibiotics.
- Wockhardt takes Nadoxin patent case to high courtDomestic pharma major Wockhardt has filed a case with the Bombay High Court, after the Indian Patent office rejected its patent application...
Load More
